Inventor · disambiguated record
William Salomon
Also filed as: SALOMON WILLIAM · Salomon William Edward
35 granted patents·18 pending applications·910 citations·filing 2008–2025
98Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS VI LLC21PHIO PHARM CORP15KHVOROVA ANASTASIA6RXI PHARMACEUTICALS CORP6WOOLF TOD M2
Top patents by PatentIndex Score
53 records- 0199US8796443B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2009·Granted Aug 5, 2014·105 cites·19 claims
- 0298US10633654B2Modified RNAi polynucleotides and uses thereofPHIO PHARM CORP·Filed 2018·Granted Apr 28, 2020·32 cites·20 claims
- 0398US10479992B2RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionalityPHIO PHARM CORP·Filed 2017·Granted Nov 19, 2019·27 cites·20 claims
- 0498US9938530B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted Apr 10, 2018·25 cites·19 claims
- 0598US9303259B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2013·Granted Apr 5, 2016·46 cites·12 claims
- 0698US9175289B2Reduced size self-delivering RNAi compoundsRXI PHARMACEUTICALS CORP·Filed 2014·Granted Nov 3, 2015·80 cites·17 claims
- 0798US9080171B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2011·Granted Jul 14, 2015·91 cites·15 claims
- 0898US8664189B2RNA interference in skin indicationsKHVOROVA ANASTASIA·Filed 2009·Granted Mar 4, 2014·60 cites·2 claims
- 0997US10913948B2RNA interference in dermal and fibrotic indicationsPHIO PHARM CORP·Filed 2018·Granted Feb 9, 2021·21 cites·7 claims
- 1097US10774330B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2015·Granted Sep 15, 2020·15 cites·19 claims
- 1197US10662430B2RNA interference in ocular indicationsPHIO PHARM CORP·Filed 2018·Granted May 26, 2020·14 cites·19 claims
- 1297US9745574B2RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionalityWOOLF TOD M·Filed 2010·Granted Aug 29, 2017·44 cites·18 claims
- 1397US9340786B2RNA interference in dermal and fibrotic indicationsKHVOROVA ANASTASIA·Filed 2011·Granted May 17, 2016·49 cites·20 claims
- 1496US11667915B2RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionalityPHIO PHARM CORP·Filed 2019·Granted Jun 6, 2023·10 cites·20 claims
- 1596US10240149B2Reduced size self-delivering RNAi compoundsPHIO PHARM CORP·Filed 2015·Granted Mar 26, 2019·23 cites·21 claims
- 1696US10184124B2RNA interference in ocular indicationsRXI PHARMACEUTICALS CORP·Filed 2015·Granted Jan 22, 2019·23 cites·14 claims
- 1796US10041073B2Reduced size self-delivering RNAi compoundsKHVOROVA ANASTASIA·Filed 2011·Granted Aug 7, 2018·24 cites·24 claims
- 1896US9963702B2RNA interference in dermal and fibrotic indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted May 8, 2018·23 cites·20 claims
- 1996US9074211B2Inhibition of MAP4K4 through RNAIWOOLF TOD M·Filed 2009·Granted Jul 7, 2015·50 cites·11 claims
- 2095US12157898B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Dec 3, 2024·4 cites·17 claims
- 2195US10138485B2Neutral nanotransportersKHVOROVA ANASTASIA·Filed 2009·Granted Nov 27, 2018·22 cites·15 claims
- 2295US9095504B2RNA interference in ocular indicationsLIBERTINE LYN·Filed 2011·Granted Aug 4, 2015·50 cites·10 claims
- 2394US12065669B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Aug 20, 2024·4 cites·26 claims
- 2494US12037602B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Jul 16, 2024·4 cites·26 claims
- 2594US11118178B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2019·Granted Sep 14, 2021·8 cites·10 claims
- 2694US10876119B2Reduced size self-delivering RNAI compoundsPHIO PHARM CORP·Filed 2018·Granted Dec 29, 2020·7 cites·20 claims
- 2794US10815485B2RNA interference in skin indicationsPHIO PHARM CORP·Filed 2018·Granted Oct 27, 2020·8 cites·5 claims
- 2893US12454706B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Granted Oct 28, 2025·1 cites·22 claims
- 2993US11584933B2RNA interference in ocular indicationsPHIO PHARM CORP·Filed 2020·Granted Feb 21, 2023·2 cites·20 claims
- 3092US12270029B2CFTR-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Apr 8, 2025·3 cites·15 claims
- 3190US11396654B2Neutral nanotransportersPHIO PHARM CORP·Filed 2018·Granted Jul 26, 2022·4 cites·19 claims
- 3290US10131904B2Modified RNAi polynucleotides and uses thereofPAVCO PAMELA A·Filed 2009·Granted Nov 20, 2018·23 cites·8 claims
- 3388US12031129B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2019·Granted Jul 9, 2024·3 cites·16 claims
- 3486US11254940B2Inhibition of MAP4K4 through RNAiPHIO PHARM CORP·Filed 2015·Granted Feb 22, 2022·5 cites·9 claims
- 3585US2025346927A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 3681US12398392B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Granted Aug 26, 2025·0 cites·18 claims
- 3779US2023272430A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 3877US2021147849A1Reduced size self-delivering rnai compoundsPHIO PHARM CORP·Filed 2020·Application pending·0 cites
- 3972US2021261968A1Rna interference in dermal and fibrotic indicationsPHIO PHARM CORP·Filed 2021·Application pending·0 cites
- 4067US2024252682A1Hbb-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Application pending·0 cites
- 4165US2024084334A1Serpina-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 4264US2023332184A1Template guide rna moleculesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 4363US2023348939A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 4462US2023242899A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 4562US2024374759A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 4662US2023235358A1Host defense suppressing methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 4762US2025179482A1Cftr-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 4861US2024263153A1Integrase compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 4960US2024240219A1Methods of enriching for circular polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 5057US2024042058A1Tissue-specific methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →